Welcome to the inaugural edition of the Deep Tech Dispatch, the weekly newsletter from DeepTech.Intel. Each week, we surface the most significant developments across five frontier technology sectors: humanoid robotics, brain-computer interfaces, quantum computing, small modular reactors, and synthetic biology.
Humanoid Robotics: Figure Expands BMW Deployment to Second Factory
Figure announced that its Figure 02 humanoid robots will expand from a single BMW manufacturing line in Spartanburg, South Carolina, to a second factory in Dingolfing, Germany. The robots are performing materials handling and quality inspection tasks alongside human workers. Figure reports that units are operating at 18 hours of uptime per day, with task success rates above 94% on trained workflows. This European expansion marks a milestone for humanoid robotics adoption in the automotive sector and validates BMW's continued investment in the partnership.
Full coverage on HUMANOID.INTEL
Brain-Computer Interfaces: Neuralink Reports Six-Month Follow-Up Data
Neuralink published six-month follow-up data from its second N1 implant patient, showing sustained cursor control speed and accuracy with no signal degradation relative to the three-month checkpoint. The patient, who has a C4 spinal cord injury, is now using the BCI for daily computer tasks including web browsing, email, and gaming. Thread retraction, which affected the first patient's performance temporarily, has not been observed in the second implant, suggesting design modifications have addressed the issue.
Quantum Computing: Quantinuum Demonstrates 12 Logical Qubits
Quantinuum announced a demonstration of 12 logical qubits with real-time error correction on its H2 trapped-ion processor, the highest number of simultaneously operated logical qubits reported to date. The result builds on Google's below-threshold error correction demonstration from late 2024 and brings the industry closer to the hundreds of logical qubits needed for commercially useful quantum computation. Quantinuum's result was achieved using a color code error correction scheme that the company argues scales more favorably than the surface codes used by superconducting qubit competitors.
Full coverage on QUANTUM.INTEL
Small Modular Reactors: Kairos Power Pours Concrete for Hermes Reactor Building
Kairos Power began structural concrete placement for the Hermes low-power demonstration reactor in Oak Ridge, Tennessee. Hermes is a fluoride-salt-cooled, high-temperature reactor that will not generate electricity but will demonstrate the thermal hydraulics and materials performance of the Kairos design at reactor scale. Construction remains on schedule for initial criticality in 2027. The Hermes project is partially funded by the DOE Advanced Reactor Demonstration Program and represents the first new reactor construction permit issued by the NRC in decades.
Synthetic Biology: Casgevy Real-World Data Shows 95% Sustained Response at Two Years
Vertex Pharmaceuticals and CRISPR Therapeutics presented two-year real-world follow-up data for Casgevy, the CRISPR-based gene therapy for sickle cell disease. Of 67 patients treated commercially since the December 2023 FDA approval, 95% remain free of vaso-occlusive crises at their most recent follow-up. Fetal hemoglobin levels remain elevated and stable, suggesting durable therapeutic effect. The data strengthens the case for CRISPR-based therapies and supports expanding Casgevy's label to additional hemoglobin disorders.
The Deep Tech Dispatch is published weekly by DeepTech.Intel. Subscribe to receive it in your inbox every Friday.